NAVB - Navidea Biopharmaceuticals, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
Assets
Current Assets
Cash
Cash And Cash Equivalents
3,476
4,593
1,539
Short Term Investments
799
1,798
-
Total Cash
4,275
4,593
1,539
Net Receivables
21
8,138
1,617
Inventory
-
0
1,471
Other Current Assets
678
1,102
0
Total Current Assets
4,975
13,832
10,826
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,251
1,206
3,585
Accumulated Depreciation
-1,089
-969
-2,333
Net property, plant and equipment
162
237
1,252
Equity and other investments
-
-
-
Goodwill
-
-
-
Intangible Assets
428
458
181
Other long-term assets
2,035
2,140
203
Total non-current assets
2,035
6,949
1,635
Total Assets
7,009
20,781
12,462
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
316
2,354
51,958
Accounts Payable
425
855
7,123
Taxes payable
-
-
-
Accrued liabilities
0
942
7,238
Deferred revenues
867
-
2,315
Other Current Liabilities
3,062
5,715
282
Total Current Liabilities
3,379
8,068
69,862
Non-current liabilities
Long Term Debt
-
0
9,641
Deferred taxes liabilities
-
-
-
Deferred revenues
700
-
26
Other long-term liabilities
533
665
599
Total non-current liabilities
1,233
665
10,266
Total Liabilities
4,611
8,733
80,128
Stockholders' Equity
Common Stock
200
162
156
Retained Earnings
-336,723
-319,909
-394,855
Accumulated other comprehensive income
-1
-2
-
Total stockholders' equity
1,730
11,380
-68,135
Total liabilities and stockholders' equity
7,009
20,781
12,462